Abstract. Microarray profiling of 15 adjacent normal/tumormatched esophageal squamous cell carcinoma (ESCC) specimens identified 40 up-regulated and 95 down-regulated genes. Verification of the microarray measurement by quantitative real-time reverse transcription PCR in the same set of samples as well as an additional 15 normal/tumormatched samples revealed >95% consistency. These signatures can also be used to classify a recently reported ESCC microarray dataset. Moreover, these molecular signatures were used as templates to elucidate their corresponding protein-protein interaction (PPI) networks using the PPI databases, POINT and POINeT. As a result, 18 genes, of which six were not disclosed in the initial expression profile analysis, were found to be able to serve as the minimal discriminators for distinguishing ESCC tumors from normal specimens. Of these discriminators, ten (BGN, COL1A1, COL1A2, MMP9, CD44, FN1, TGFBI, PXN, SPARC and VWF) were associated with tumor metastasis and formed a highly interactive network with the first four molecules as 'hubs'. Our study not only reveals how novel insights can be obtained from gene expression profiling, but also highlights a group of highly interacting genes associated with metastasis in ESCC.
Introduction
Esophageal carcinoma is one of the most lethal cancers in the world, with a median survival of approximately 1 to 2 years among patients amenable to surgery (1, 2) . Adenocarcinoma is the major histological subtype in Western countries, yet esophageal squamous cell carcinoma (ESCC) is the most frequent histological subtype in Asia (2) .
Microarray profiling has been used in the study of carcinogenesis, disease classification, as well as prediction of treatment response, lymph node metastasis and prognosis of ESCC (3) (4) (5) (6) (7) (8) (9) (10) (11) . However, there has been a lack of systematic analysis of the molecular markers that characterize carcinogenesis of ESCC.
In this study, we used Affymetrix GeneChip technology to identify discriminators for ESCC, which can also be used to classify a recently reported ESCC microarray dataset. Furthermore, we employed the ESCC molecular discriminators as a template to deduce a protein-protein interaction (PPI) network by using two PPI databases, the Prediction Of INTeractome (POINT) and POINeT. This resulted in the uncovering of a group of genes that not only serves as the minimal discriminators for distinguishing ESCC tumors from normal specimens, but also forms a highly interactive network involved in the metastasis of ESCC.
Materials and methods
Patients and samples. This study was approved by the Institutional Review Board of Taipei Veterans General Hospital. Fifteen patients with newly diagnosed ESCC, who had received primary curative esophageal resection, were included in this expression profile study. None of them received neoadjuvant therapy prior to the resection (Table I) . Fifteen additional adjacent normal/tumor-matched ESCC samples were obtained for quantitative real-time reverse transcription PCR (Q-RT-PCR). Informed consents were obtained from all patients. For tumor tissues, samples were obtained from the non-necrotic area of the tumor and cut into two equally sized pieces: one for storage and the other for pathological examination. Tumors were not microscopically dissected, but only those with cancer cellularity >80% under pathological examination were included for further study. For obtaining an adjacent normal counterpart, morphologically normal esophageal epithelium at least 5 cm from the tumor margin was carefully dissected from the freshly resected esophagectomy specimen and evaluated microscopically. All specimens were snap-frozen in liquid nitrogen immediately after resection and stored at -150˚C until needed for subsequent experiments. Tumor stage and grade were defined according to the American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 6th edition.
RNA isolation, reverse transcription and microarray. Total RNA was isolated from the frozen esophageal tissues as previously described (12) . The integrity of the RNA from the pooled samples was determined using a Spectra Max Plus (Molecular Devices), and the A260/A280 ratio was from 1.9 to 2.1. Reagents for hybridization and protocols for washing and staining were the same as previous methods (13) and the Affymetrix instructions (http://www.affymetrix.com/ support/technical/manuals.affx).
Data analysis, clustering algorithm, gene ontology analysis and construction of the protein-protein interaction network.
Following a quantitative scan of a chip, the images were transformed to text files containing intensity information using the GeneChip ® Operating Software developed by Affymetrix. The microarray data were analyzed using the GeneSpring ® GX 7.3.1 Software (Agilent Technologies, Santa Clara, CA, USA). A statistical comparison of gene expression between the matched normal/tumor specimens was performed using the Wilcoxon signed-rank nonparametric test, and this approach used false-discovery rate (FDR) to account for simultaneous testing on thousands of genes (multiple testing correction) (14, 15) . The difference in expression was expressed as fold change. To evaluate gene expression patterns, hierarchical clustering was carried out by the Pearson's correlation metric and average linkage. Differentially expressed genes were subjected to principal component analysis (PCA) to determine patterns in the variability of expression profiles (16) .
Gene ontology (GO) analysis was performed using FatiGO (http://fatigo.bioinfo.cnio.es/) to distinguish differential distribution. Database POINT (http://point. bioinformatics.tw/) (17) and tool POINeT (http://poinet. bioinformatics.tw/) were used to study PPI and network construction. Table I. Demographic characteristics of 15 patients with esophageal squamous cell carcinoma (ESCC) enrolled for microarray  analysis.  -----------------------------------------------------------------------------------------------------Patients  Gender  Age  Tumor location  TNM stage  AJCC stage  Differentiation - -
Q-RT-PCR analysis was used to confirm the microarray analysis data for the selected genes as described previously (12) . Primer sequences (Table II) designed using Primer Express Software (Applied Biosystems, Foster City, CA, USA) were used to perform Q-RT-PCR according to the manufacturer's instructions. To standardize the quantification of the selected target genes, DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 (DDX5) served as an internal control for their smaller variance than glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and actin ß (ACTB) by using bootstrap resampling scheme (18) , and was quantified on the same plate as the target genes. A melting-point (T m ) curve was used to identify the temperature at which only the amplicon and not the primer dimers, accounted for the SYBR Green-bound fluorescence. Assays were performed in triplicate using an Applied Biosystems Model 7700 instrument. Gene expression profiles of the Q-RT-PCR of adjacent normal/tumor-matched ESCC specimens were analyzed using the Wilcoxon signedrank test.
Results
Distinct gene expression signatures characterize adjacent normal/tumor-matched ESCC specimens. Using the Wilcoxon signed-rank test, 4947 transcripts were found differentially expressed between adjacent normal and tumor-matched ESCC specimens (p<0.05). Supervised hierarchical clustering showed two main clusters, one representing the tumor specimens and the other representing the adjacent normal tissue specimens (Fig. 1A) . The number of differentially expressed transcripts was narrowed down to 166 by using more stringent criteria (at least a 1.5-fold change with p<1x10 -6 , Fig. 1B ). The discrimination ability of these 166 transcripts was further confirmed by PCA (Fig. 1C) . The list of these 166 transcript (135 genes) discriminators, which is made up of 40 upregulated and 95 down-regulated genes, is shown in Table III . Significantly, more than two-thirds of these discriminators were known to exhibit dysregulation profiles in many cancers as determined by PubMed search (Table III) .
Differential distribution of gene-ontology (GO) terms in discriminators of ESCC.
One hundred and thirty-five discriminative genes were classified with FatiGO to distinguish differential distribution in function through GO assignment. FatiGO implements 2 x 2 tables for comparison between up-regulated and down-regulated genes, extracting a list of GO-terms that are distributed among the groups with significant differences. In the cellular component, 32 out of 40 up-regulated genes and 57 out of 95 down-regulated genes had GO assignments. A comparison of the GO-term distribution between the up-regulated and down-regulated genes suggested that the significant GO-terms (p<0.05) were involved in the extracellular matrix (up vs. down, 31.25 vs. 1.75%), the membrane (up vs. down, 15.62 vs. 52.63%), and the cell fraction (up vs. down, 0 vs. 26.32%). In terms of molecular function, 33 out of the 40 up-regulated genes and 63 out of the 95 down-regulated had GO assignments. The only significant GO-term (p<0.05) involved was metallopeptidase activity (up vs. down, 30.43 vs. 0%) (Table IV) . In contrast, there was no significant GO-term for any biological process among these ESCC discriminators. Together, the GO assignments highlighted the functional categories of the discriminative genes involved in the tumorigenesis of ESCC. Table II . Primers used for the Q-RT-PCR validation. 
Confirmation of the microarray measurement by Q-RT-PCR.
Q-RT-PCR was performed to verify the microarray findings using 13 pairs of samples that were used in the microarray analysis as well as an additional 15 adjacent normal/tumormatched ESCC samples. Two of the up-regulated discriminators, aurora kinase A (AURKA) and transforming growth factor, ß-induced, 68 kDa (TGFBI), were also found overexpressed in most of the tumors in comparison with the adjacent normal samples by Q-RT-PCR ( Fig. 2A and B) . Together, a total of 29 genes, including 19 up-regulated and 10 down-regulated ones, were selected from the genes listed in Table III . In 15 normal/tumor-matched samples, 26 of the 29 selected discriminators were shown differentially expressed between adjacent normal and tumor-matched specimens by Q-RT-PCR (p<0.05, asterisk) ( Table V) . The results were in good agreement with those from the microarray data.
Comparison of this expression profile with a published dataset. By comparing our expression profile with a recently published microarray dataset from 20 matched adjacent normal and tumor specimens of ESCC (8) , 75 genes (25 upand 50 down-regulated genes) (Table III) exhibited similar fold-changes without any contradictory result. This is a notable observation since there is usually a low percent overlap of differentially expressed genes observed when compared to the union of the different microarray platforms (19) . 
LOC285412
Similar to Epidermal Langerhans cell protein LCP1 F TTGGGTCACATAGTAGTAGAGT R TGCCATCTGTTCTTAGACT
To address whether the newly identified 135 ESCC (Table III) and 26 Q-RT-PCR validated (Table V) discriminators could be applied to classify other ESCC microarray datasets, we applied PCA to test their capability of discrimination in this recently published dataset (8) . By using relative expression levels of 20 normal/tumor-matched ESCC specimens (http://www.ebi.ac.uk/microarray-as/aer/ dataselection?expid=956697506), PCA correctly classified most of these 20 matched specimens by our ESCC signatures (Fig. 3) .
From 135 molecular signatures to network construction. By using POINT and POINeT, 40 up-regulated genes (labeled in blue, yellow or red) were presented as queries to search for their interacting proteins (labeled in grey), and most of them interacted with other queries and formed a highly connective network (Fig. 4A) . Five of them interacted with each other [matrix metallopeptidase-9 (MMP9), collagen, type I ·2 (COL1A2), ·1 (COL1A1), biglycan (BGN)] or themselves [CDC28 protein kinase regulatory subunit 2 (CKS2)]. These queries (red), which interact with more than one query, are referred to as hubs. Another four proteins [TPX2, microtubule-associated, homolog (Xenopus laevis) (TPX2)/AURKA and CKS2/cell division cycle 2 (CDC2), labeled in yellow/ red] also interacted with each other. It is believed that the increased number of interacting proteins associated with a query (or hub) is the most important feature that determines the essentialness of a given protein (20) . We then added the interacting proteins (green) of these selected queries (Fig. 4B) . In order to narrow down the network, these interacting proteins (green) must exhibit differentially expressed patterns (p<0.05) from the microarray data to remain in the network (Fig. 4C) . In contrast, of the 95 down-regulated genes, only four of them [periplakin (PPL)/envoplakin (EVPL) and tight junction protein 3 (TJP3)/protein 1 (TJP1), labeled in yellow] interacted with each other or through additional interacting proteins (green) (Fig. 4D) . However, these additional interacting proteins (green) (Fig. 4E) did not exhibit differential gene expression patterns between adjacent normal and tumormatched specimens, and were therefore removed from the network (Fig. 4F) . These analyses demonstrated that the Table III . Differentially expressed genes of ESCC. 
-------------------------------------------------

MMP1 b,c P11 b,c RAGD b INHBA b,c ARS b,c CEACAM1 b,c MMP3 b,c IL1RN b ABLIM1 b,c MMP10 b,c SGP28 NMU b,c SPP1 b,c SCEL b PITX1 b SERPINH1 b,c CLIC3 KIAA0089 CST1 MYH11 b EHD3 b,c IMP-2 b,c CYP4B1 b,c TJP3 d COL1A1 b,d TMPRSS2 b,c IL8RB b,c COL1A2 b,c,d KLK13 b CCNG2 b,c OSF-2 b,c CLCA4 KIAA0790 MMP11 b,c HPGD b,c CEACAM7 b,c APOL1 RHCG FLJ13841 b,c APOE b FUT6 b MGLL b,c BGN b,d KIAA0227 NEBL b,c CDC2 b,c,d XLKD1 NUCB2 b,c FAP b,c DESC1 b CES2 b PLAU b,c GPX3 b,c GALNT12 b MMP9 b,d CEACAM5 RAB25 b IFI30 b,c SERPINB4 MGC11335 NETO2 FLG CAST b,c G1P3 b,c SERPINB3 b MAPK3 ECT2 b,c EPS8R1 CYP2C9 b PIR51 b,c TGM1 b,c ZNF426 DPP3 b CYP3A5 b,c SORT1 CKS2 b,c,d PPL b,c,d TM4SF6 b,c LOXL2 b,c HLF b,c EPS8R2 LOC146909 PRSS3 b,c PIG3 TPX2 b,d EMP1 b,c ESPL1 DKFZp762E1312 EDN3 b,c FLJ10948 MCM2 b MGC4309 KIAA0165 KIF14 b,c HSHUR7SEQ GSN b AURKA b,c,d SERPINB13 b LOC57228 HMGB3 b,c FLJ22408 TIAM1 b,c PSMB9 b,c PTN b,c LPIN1 b,c ANP32E BENE b,c RANBP9 CENPA b,c CRABP2 b,c TJP1 b,c,d LAPTM4B b,c CYP2C18 FYCO1 ASPM b FLJ21511 b FTS KPNA2 b,c ATP1A2 NCOA1 b,c ZNF185 b CD24 b,c le1 SERPINB1 b,c CYP4F12 SULT2B1 UPK1A b,c TRY6 SERPINB2 b,c FUT3 b,c ID4 b IL18 b,c EVPL b,c,d PRSS2 b,c CYP3A5P2
Genes revealed by protein-protein interaction network analysis (6 genes, 10 transcripts) Up-regulated (5 genes) Down-regulated (1 gene) -
------------------------------------------------
Gene expression in tumor tissue <1.5-fold of the normal counterpart was defined as down-regulation and one with >1.5-fold of the normal counterpart was defined as up-regulation. b These genes have been reported in ESCC or others.
c These genes showed similar fold-changes as reported by Greenawalt et al. d These genes served as the minimal discriminators based on components of the protein-protein interaction network of ESCC (Fig. 4) . generation of a highly interactive network from the overexpressed ESCC gene signatures might not be a random process, because the chance to form an interactive network was not correlated with the size of the dataset (the larger downregulated gene dataset was unable to form such a network).
To explore the existence of minimal discriminators to distinguish ESCC from matched adjacent normal specimens, those genes appearing in the final network, including 18 genes (23 transcripts) from Fig. 4C and F, consisting of 13 upregulated and 5 down-regulated ones, were used. Six of them were not in the list of 135 discriminators (Table III) . The gene expression patterns of 16 out of the 18 genes were confirmed by Q-RT-PCR (Table V) . Using supervised hierarchical clustering to arrange the transcripts (y-axis) and samples (x-axis), these 18 genes were able to serve as the smallest group of discriminators between tumor and adjacent normalmatched specimens in ESCC (Fig. 5) . Finally, a literature review showed that 10 [BGN, COL1A1, COL1A2, MMP9, CD44, fibronectin 1 (FN1), TGFBI, paxillin (PXN), secreted protein, acidic, cysteine-rich (SPARC) and von Willebrand factor (VWF)] out of the 18 genes from the constructed networks of ESCC were associated with tumor metastasis (21) (22) (23) (24) (25) (26) (27) (28) .
Discussion
In this gene profiling study of ESCC, we were able to identify 135 normal/tumor discriminators, for which the ability of classification was confirmed in another dataset of microarray of ESCC (Fig. 3) . Furthermore, in combination with a more functional-based PPI study, we identified 18 highly interacting genes, of which six were not disclosed in the initial expression profile analysis using stringent statistical criteria (Table III) . Nonetheless, these 18 genes still served as the smallest group of normal/tumor discriminators (Fig. 5) .
AURKA is an up-regulated gene from among the final 18 discriminators. AURKA, which encodes a serine/threonine kinase associated with chromosomal distribution, has been correlated with distant lymph node metastasis and poor prognosis in ESCC (29) . AURKA can phosphorylate and interact with TPX2, and our study revealed the same gene expression patterns of both genes in ESCC specimens. Similar expression profiles were also observed between another two interacting genes, CKS2 and CDC2 (Table V and Fig. 5) . Notably, these genes represented the 'proliferation signature' identified by Greenawalt et al (8) . This result supports the view that common expression clusters could be functionally linked (30) , and the conversion of gene expression profiling into functional features, such as protein-protein interactions, could reveal novel insights into the carcinogenesis of ESCC.
A set of 10 metastasis-associated genes, including MMP9,  BGN, COL1A1, COL1A2, SPARC, CD44, TGFBI, PXN, FN1 and VWF, form a highly interactive network (Fig. 4) . MMP9, BGN, COL1A1 and COL1A2, which were identified as 'hubs' due to their interactions with more than one query in POINT, were identified as significantly up-regulated genes with GOterm 'extracellular matrix' (Table IV) . SPARC and COL1A2 were also revealed as genes in 'SPARC cluster' by Greenawalt et al (8) . COL1A1 has been shown to induce disruption of cellcell contacts and promote proliferation of pancreatic carcinoma cells (24) . Up-regulation of TGFBI has been reported in oral cancer (31) , and TGFBI-induced expression of BGN has been implicated in cellular adhesion and migration (25) . High SPARC and FN1 expression was significantly associated with poor prognosis in ESCC (7, 21, 23) . Overexpression of PXN, a multi-domain adaptor that recruits both structural and signaling molecules to focal adhesions, has been associated with enhanced metastatic potential of osteosarcoma (22) . MMP9 is a member of the metallopeptidases. CD44 is a cellsurface glycoprotein involved in cell-cell interactions, cell adhesion and migration. Overexpression of MMP9 and CD44 has been correlated with metastasis and poor prognosis of ESCC (26, 28) . VWF is a glycoprotein functioning as both an antihemophilic factor carrier and a platelet-vessel wall mediator in the blood coagulation system, and in tumor cells it could play a protective role against dissemination (27) . Table IV . Comparison of Gene-Oncology (GO)-term distribution between up-and down-regulated genes. 
Membrane, double layer of lipid molecule and its associated proteins in eukaryotes. Cell fraction, a generic term for parts of cells prepared by disruptive biochemical techniques which included soluble, insoluble, PME, and membrane fractions.
By using the 9 overexpressed genes as a basis and searching related genes through literature review, we were able to create an invasion and metastasis model for ESCC (Fig. 6) . Transforming growth factor ß (TGFB) binds to its receptor (TGFBR) to modulate SMAD2/3 signaling with subsequent induction of matrix metalloproteinase-2 (MMP2), collagen type 1, SPARC, and TGFB expression (32) (33) (34) . SPARC could have positive feedback interaction with the TGFBR complex (34) . The activated TGFBR complex could phosphorylate SMAD3 and induce BGN expression through the p38MAPK cascade (25), as well as promote FN1 (32) and TGFBI expression. TGFBI, FN1 and collagen type 1 could Table V . Gene expression profiles of the Q-RT-PCR of 15 pair-wised ESCC specimens were analyzed using Wilcoxon signedrank test. 
-----------------------------------------------------------------------------------------------------
a In total, 26 of 29 genes from 135 discriminators were differentially expressed between normal and tumor specimens. b p<0.05. Figure 6 . A proposed model for the putative relationships between tumor metastasis-associated genes in ESCC. Genes marked as green were those revealed by PPI analysis. FAK, focal-adhesion kinase; CRK, v-crk sarcoma virus CT10 oncogene homolog. For the other abbreviations and description of the model, please see Table II and text for details.
bind integrin and stimulate the expression of PXN protein (35) , which then activates the p38MAPK pathway. In parallel, TGFB1 induces the interaction between FN1 and fibronectin receptor (FNR) (36) , which increases the expression of MMP9 through the v-raf-1 murine leukemia viral oncogene homolog (RAF1)/extracellular signal-regulated kinase (ERK) pathway (21, 37) . CD44 serves as an anchor for MMP9 on the cell surface (38) , and the CD44/MMP9 complex, BGN and collagen type 1 could then mediate tumor invasion and metastasis (24, 25, 38) . Among the 4 down-regulated genes, both PPL and EVPL encode components of desmosomes. EVPL is localized at the tylosis esophageal cancer (TOC) locus, which is commonly deleted in ESCC (39) . PPL was found down-regulated in ESCC by proteomic analysis (40) . TJP1 and TJP3 are membrane proteins located at intercellular tight junctions, and TJP1 was found down-regulated in colon cancer cell with liver metastasis (41) . Although the 4 down-regulated genes did not form a highly interacting network, their roles in the pathogenesis of ESCC still warrant further study.
In summary, our expression profiles provide diseasespecific expression signatures for ESCC. Furthermore, by using PPI databases, we were able to identify additional important differentially expressed genes, and convert them into a functional network which is most likely involved in metastasis of ESCC. Based on the findings presented here, we postulate a model depicting the signaling pathways which induce cell invasion and metastasis of ESCC, and we offer a series of potential therapeutic targets for ESCC.
